Skip to main content
Erschienen in: Clinical Drug Investigation 7/2020

01.07.2020 | Publisher Correction

Expression of Concern to: Fetal Safety of Dydrogesterone Exposure in the First Trimester of Pregnancy

verfasst von: Gideon Koren, Daniella Gilboa, Rachel Katz

Erschienen in: Clinical Drug Investigation | Ausgabe 7/2020

Einloggen, um Zugang zu erhalten

Excerpt

The Editor-in-Chief of Clinical Drug Investigation has become aware that this article [1] contains a number of errors and inconsistencies. In addition, concerns have also been raised regarding the study design and statistical analysis. These concerns are being investigated and an update will be provided once a resolution has been reached. Until then the conclusions of the study should be interpreted with caution. …
Metadaten
Titel
Expression of Concern to: Fetal Safety of Dydrogesterone Exposure in the First Trimester of Pregnancy
verfasst von
Gideon Koren
Daniella Gilboa
Rachel Katz
Publikationsdatum
01.07.2020
Verlag
Springer International Publishing
Erschienen in
Clinical Drug Investigation / Ausgabe 7/2020
Print ISSN: 1173-2563
Elektronische ISSN: 1179-1918
DOI
https://doi.org/10.1007/s40261-019-00884-4

Weitere Artikel der Ausgabe 7/2020

Clinical Drug Investigation 7/2020 Zur Ausgabe